Z. Abdul Samad and A. Jameel, “FDA Approves Axatilimab: A New Standard in Chronic Graft-Versus-Host Disease Therapy ”, J Pak Med Assoc, vol. 75, no. 12, pp. 2010–2011, Nov. 2025.